Seyed Ebrahim Alavi

2.4k total citations
76 papers, 1.7k citations indexed

About

Seyed Ebrahim Alavi is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Seyed Ebrahim Alavi has authored 76 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Biomaterials, 18 papers in Biomedical Engineering and 15 papers in Molecular Biology. Recurrent topics in Seyed Ebrahim Alavi's work include Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (13 papers) and Advanced Drug Delivery Systems (11 papers). Seyed Ebrahim Alavi is often cited by papers focused on Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (13 papers) and Advanced Drug Delivery Systems (11 papers). Seyed Ebrahim Alavi collaborates with scholars based in Iran, Australia and Saudi Arabia. Seyed Ebrahim Alavi's co-authors include Hasan Ebrahimi Shahmabadi, Maedeh Koohi Moftakhari Esfahani, Aun Raza, Sitah Alharthi, Peter J. Cabot, Peter M. Moyle, Azim Akbarzadeh, Azim Akbarzadeh, Fatemeh Movahedi and Nazrul Islam and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Seyed Ebrahim Alavi

74 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seyed Ebrahim Alavi Iran 26 692 540 460 325 170 76 1.7k
Jianhong Yang China 24 652 0.9× 426 0.8× 629 1.4× 340 1.0× 180 1.1× 77 1.8k
Afsana Sheikh India 27 701 1.0× 667 1.2× 798 1.7× 265 0.8× 207 1.2× 44 1.9k
Ameya R. Kirtane United States 19 458 0.7× 548 1.0× 473 1.0× 235 0.7× 192 1.1× 36 1.6k
Yuanyuan Shen China 28 705 1.0× 589 1.1× 527 1.1× 247 0.8× 231 1.4× 77 1.9k
Hasan Ebrahimi Shahmabadi Iran 24 539 0.8× 412 0.8× 312 0.7× 184 0.6× 164 1.0× 63 1.3k
Piping Lv China 14 656 0.9× 508 0.9× 511 1.1× 424 1.3× 249 1.5× 16 1.5k
Bernard Učakar Belgium 26 954 1.4× 751 1.4× 534 1.2× 425 1.3× 157 0.9× 54 2.3k
Zhaowu Zeng China 15 625 0.9× 421 0.8× 546 1.2× 305 0.9× 245 1.4× 36 1.6k
B.H. Jaswanth Gowda India 26 643 0.9× 678 1.3× 419 0.9× 341 1.0× 341 2.0× 52 1.8k
Riyaz Ali M. Osmani India 24 533 0.8× 419 0.8× 387 0.8× 653 2.0× 167 1.0× 117 1.8k

Countries citing papers authored by Seyed Ebrahim Alavi

Since Specialization
Citations

This map shows the geographic impact of Seyed Ebrahim Alavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seyed Ebrahim Alavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seyed Ebrahim Alavi more than expected).

Fields of papers citing papers by Seyed Ebrahim Alavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seyed Ebrahim Alavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seyed Ebrahim Alavi. The network helps show where Seyed Ebrahim Alavi may publish in the future.

Co-authorship network of co-authors of Seyed Ebrahim Alavi

This figure shows the co-authorship network connecting the top 25 collaborators of Seyed Ebrahim Alavi. A scholar is included among the top collaborators of Seyed Ebrahim Alavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seyed Ebrahim Alavi. Seyed Ebrahim Alavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alharthi, Sitah, et al.. (2025). Targeted antibacterial and anticancer therapeutics: PEGylated liposomal delivery of turmeric and cinnamon extracts- in vitro and in vivo efficacy. Drug Development and Industrial Pharmacy. 51(3). 231–243. 3 indexed citations
3.
Alavi, Seyed Ebrahim, et al.. (2024). Revolutionizing Wound Healing: Exploring Scarless Solutions through Drug Delivery Innovations. Molecular Pharmaceutics. 21(3). 1056–1076. 21 indexed citations
4.
Qureshi, Sundus Saeed, Seyed Ebrahim Alavi, & Yousuf Mohammed. (2024). Microsponges: Development, Characterization, and Key Physicochemical Properties. Assay and Drug Development Technologies. 22(5). 229–245. 1 indexed citations
5.
Alavi, Seyed Ebrahim, et al.. (2024). Microfluidics for personalized drug delivery. Drug Discovery Today. 29(4). 103936–103936. 41 indexed citations
6.
Alharthi, Sitah, Ghallab Alotaibi, Aun Raza, et al.. (2024). Enhancing the therapeutic landscape of cutaneous leishmaniasis: pegylated liposomal delivery of miltefosine for controlled release and improved efficacy. Journal of Drug Delivery Science and Technology. 96. 105735–105735. 6 indexed citations
7.
Imran, Mohammad, et al.. (2023). Science of, and insights into, thermodynamic principles for dermal formulations. Drug Discovery Today. 28(4). 103521–103521. 25 indexed citations
8.
Sharma, Lavanya Ajay, et al.. (2023). Peri-Implantitis Therapy Using Surgical Methods: A Systematic Review. Applied Sciences. 13(5). 3166–3166. 8 indexed citations
9.
Alavi, Seyed Ebrahim, et al.. (2023). Resorbable GBR Scaffolds in Oral and Maxillofacial Tissue Engineering: Design, Fabrication, and Applications. Journal of Clinical Medicine. 12(22). 6962–6962. 30 indexed citations
10.
Alavi, Seyed Ebrahim, et al.. (2023). Bioresponsive drug delivery systems. Drug Discovery Today. 29(1). 103849–103849. 42 indexed citations
11.
Raza, Aun, et al.. (2022). Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics. 14(10). 2183–2183. 60 indexed citations
12.
Esfahani, Maedeh Koohi Moftakhari, Seyed Ebrahim Alavi, Peter J. Cabot, Nazrul Islam, & Emad L. Izake. (2022). β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics. 14(4). 884–884. 20 indexed citations
13.
Alavi, Seyed Ebrahim, Peter J. Cabot, Aun Raza, & Peter M. Moyle. (2021). Developing GLP-1 Conjugated Self-Assembling Nanofibers Using Copper-Catalyzed Alkyne–Azide Cycloaddition and Evaluation of Their Biological Activity. Bioconjugate Chemistry. 32(4). 810–820. 31 indexed citations
16.
Esfahani, Maedeh Koohi Moftakhari, et al.. (2020). Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. Journal of drug targeting. 29(2). 131–154. 91 indexed citations
17.
Alavi, Seyed Ebrahim, Peter J. Cabot, & Peter M. Moyle. (2019). Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency. Molecular Pharmaceutics. 16(6). 2278–2295. 75 indexed citations
18.
Rasouli, Rahimeh, et al.. (2015). Investigation of effective factors in preparation of polybutyl cyanoacrylate nanoparticles by emulsion polymerization. 5(19). 32–38. 2 indexed citations
19.
Alavi, Seyed Ebrahim, et al.. (2014). Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study. Tumor Biology. 35(8). 7491–7497. 24 indexed citations
20.
Qujeq, Durdi, et al.. (2013). Effect of Sodium Chloride on Efficiency of Cisplatinum Dissolved in Dimethyl Sulfoxide: An In Vitro Study. Indian Journal of Clinical Biochemistry. 29(2). 242–245. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026